(Q36564101)

14 August 2017

1 reference

title

Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives (English)

1 reference

14 August 2017

Simon L Croft

1

1 reference

PubMed ID

16904717

14 August 2017

Juergen Engel

series ordinal

2

1 reference

14 August 2017

14 August 2006

1 reference

Transactions of the Royal Society of Tropical Medicine and Hygiene

14 August 2017

1 reference

14 August 2017

100 Suppl 1

1 reference

14 August 2017

S4-8

1 reference

Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Antileishmanial ring-substituted ether phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Antileishmanial activity of the ether phospholipid ilmofosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Chemotherapy of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Hexadecylphosphocholine: a new and selective antitumor drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

PAF receptor structure: A hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Trial of oral miltefosine for visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Metabolism of ether lysophospholipids in Leishmania donovani promastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Enhancement of Glucantime therapy of murine Leishmania donovani infection by a synthetic immunopotentiating compound (CP-46,665-1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Antileishmanial activity of rac-1-dodecyl-2-octanamido-2-deoxy-glycerophosphocholine, a new dialkylglycerophosphocholine, in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Phase I and pharmacokinetic study of the cytotoxic ether lipid ilmofosine administered by weekly two-hour infusion in patients with advanced solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Metabolism of 1-0-[1'-14C]octadecyl-sn-glycerol in Leishmania donovani promastigotes. Ether lipid synthesis and degradation of the ether bond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

D-21266, a new heterocyclic alkylphospholipid with antitumour activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Syntheses and antimicrobial activities of alkyl lysophospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Ether lipids in oncology-welcoming address

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2006.03.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2006.03.009

1 reference

14 August 2017

1 reference

PubMed ID

16904717